Edwards Lifesciences (EW) Tops Q1 EPS by 12c, Narrows FY 2017 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Edwards Lifesciences (EW) PT Raised to $118 at Stifel
April 26, 2017 8:36 AM EDTStifel raised its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $114.00) while maintaining a Buy rating. 1Q17 EPS of $0.94 beat consensus projections by $0.12. The quarters impressive EPS beat was driven by broad based top-line outperformance across the companys product lines and... More
